Drive-thru COVID-19 vaccination sites have opened in Prince Albert and North Battleford, and re-opened in Regina Saturday.
The Saskatchewan Health Authority said it’s expediting the opening of additional drive-thru and walk-in clinics in communities to deliver the vaccines. A walk-in clinic has also opened in Weyburn Saturday, and a drive-thru clinic opened Friday in Swift Current.
The drive-thru and walk-in clinics are delivering vaccines on a first-come, first-served basis. Only people 55 years of age and older are eligible for the drive-thru and walk-in clinics. Vaccine appointments are currently available to residents 58 and older, and to medically vulenerable people with a letter from the SHA.
The SHA said while vaccine supply is high, wait times are expected and times can be checked online. On Saturday at 9:32 a.m., the SHA temproarily closed the line at the Regina site because there was a 6+ hour wait time. As of 11 a.m., the wait time was listed on the website as 4+ hours.
We have temporarily closed the line at the COVID-19 vaccine drive-thru clinic in <a href=”https://twitter.com/hashtag/yqr?src=hash&ref_src=twsrc%5Etfw”>#yqr</a> as the wait time is 6+ hours. Anyone in line will be vaccinated and others may try later. Clinic closes at 4pm and reopens at 8:30am Easter Sunday. For wait times go here <a href=”https://t.co/zRaTZ5ynW9″>https://t.co/zRaTZ5ynW9</a>
More drive-thru sites are anticipated to open this week across the province. The SHA website said the Lloydminster site is expected to open on Sunday, the Saskatoon drive-thru site is anticipated to open on Monday and the Yorkton and Weyburn sites are anticipated to open Tuesday.
On Wednesday, the Moose Jaw walk-in site is expected to open and the Moose Jaw drive-in site is expected to be open Friday, April 9.
The SHA said people who go to the drive-thru or walk-in clinics are asked to cancel any booked vaccine appointments they have. People are able to cancel phone and online bookings at the Saskatchewan vaccine booking website.
COVID cases in Ontario could spike to 30,000 per day by June
TORONTO (Reuters) – New cases of COVID-19 in Canada‘s most populous province could rise more than six fold, topping 30,000 per day by early June if public health measures are weak and vaccination rates remain flat, a panel of experts advising the province of Ontario said on Friday.
Even if measures to control the virus are “moderate,” the number of patients in Ontario ICUs could reach 2,000 in May, up from 695 on Friday.
The College of Physicians and Surgeons of Ontario told doctors last week they may soon have to decide who can and cannot receive intensive care.
(Reporting by Allison Martell; Editing by Chris Reese)
Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track
ZURICH (Reuters) – U.S. drugmaker Moderna expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union– and Swiss-bound shipments are on track, a spokesperson said.
The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland’s Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States.
“The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain,” Moderna said in a statement.
Lonza didn’t immediately return a phone call and email seeking comment on any issues in its production.
(Reporting by John Miller; editing by David Evans)
Moderna says vaccines to Canada to be delayed due to Europe shortfall
(Reuters) -Moderna Inc said on Friday a shortfall in COVID-19 vaccine doses from its European supply chain will lead to a delay in deliveries to some countries including Canada.
She said one to two million doses of the 12.3 million doses scheduled for delivery by Moderna in the second quarter would be delayed until the third.
Moderna officials in Europe did not immediately comment on the reason for the delays or give the total number of countries that would be impacted.
“Vaccine manufacturing is a highly complex process and a number of elements, including human and material resources have factored into this volatility,” said Patricia Gauthier, an executive at Moderna Canada.
Canada has distributed a total of 2.82 million doses of the Moderna vaccine as of April 14 and 12.7 million doses of COVID-19 vaccines in total.
Moderna has been aiming to deliver 700 million to 1 billion doses of the COVID-19 globally this year, including from plants in Europe and the United States.
Swiss contract drug manufacturer Lonza makes active ingredients for Moderna’s vaccine in Visp, but it was still ramping up three new production lines that once operational would be able to produce 300 million shots annually.
The current supply, demand and distribution landscape has led the drugmaker to make adjustments in the expected second-quarter deliveries, Gauthier said.
(Reporting by Manas Mishra in Bengaluru, Allison Martell in Toronto and John Miller in Zurich; Editing by Arun Koyyur)